Literature DB >> 24810832

Fibrosarcoma development 15 years after curettage and bone grafting of giant cell tumor of bone.

JuMing Li, Yan Zhu, YongZhong Wei.   

Abstract

Malignant transformation of conventional giant cell tumor of bone is rare and usually occurs with irradiation. This article describes a case of malignant transformation of a giant cell tumor 15 years after initial curettage and bone graft. A 35-year-old man was admitted to the hospital with a recurrent giant cell tumor of the distal femur. On presentation, the patient reported the insidious onset of a dull aching pain in the distal part of the left thigh 4 months prior to admission. Radiographs revealed a destructive lesion in the left distal femur. Needle biopsy revealed recurrence of giant cell tumor with suspected malignant transformation. The patient underwent en bloc resection of the distal femur with adequately wide margins and reconstruction of the knee joint with a prosthesis. Pathological findings showed malignant transformation of a giant cell tumor to high-grade spindle cell sarcoma. Immunohistochemistry showed diffuse and strong p53 expression. A diagnosis of secondary fibrosarcoma was made after discussion. Unfortunately, the tumor proved to be highly resistant to the chemotherapy, and the patient died of multiple lung metastases 14 months after the diagnosis of malignant transformation. What has to be stressed in this case is that any late recurrence must be approached considering the possibility of a secondary induced primary tumor. Because of the rarity of this disease, the effective therapeutic strategy for fibrosarcoma secondary to giant cell tumor is lacking. In addition, identification of the p53 mutation may help in diagnosing cases of potential malignant transformation of giant cell tumor. Copyright 2014, SLACK Incorporated.

Entities:  

Mesh:

Year:  2014        PMID: 24810832     DOI: 10.3928/01477447-20140430-66

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  6 in total

Review 1.  The rare primary bone sarcomas: imaging-pathological correlation.

Authors:  Rupert Berkeley; Vanghelita Andrei; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2021-01-07       Impact factor: 2.199

Review 2.  Denosumab in Patients with Giant Cell Tumor and Its Recurrence: A Systematic Review.

Authors:  Khodamorad Jamshidi; Mohamad Gharehdaghi; Sami Sam Hajialiloo; Masoud Mirkazemi; Kamran Ghaffarzadehgan; Azra Izanloo
Journal:  Arch Bone Jt Surg       Date:  2018-07

Review 3.  A High-grade Sarcoma Arising in a Patient With Recurrent Benign Giant Cell Tumor of the Proximal Tibia While Receiving Treatment With Denosumab.

Authors:  Luis A Aponte-Tinao; Nicolas S Piuzzi; Pablo Roitman; German L Farfalli
Journal:  Clin Orthop Relat Res       Date:  2015-03-11       Impact factor: 4.176

Review 4.  Malignant giant cell tumour of bone: a review of clinical, pathological and imaging features.

Authors:  Ismail Tahir; Vanghelita Andrei; Robin Pollock; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2021-09-25       Impact factor: 2.199

5.  Histological Regression of Giant Cell Tumor of Bone Following RANK Ligand Inhibition.

Authors:  Martin F Dietrich; Dominick Cavuoti; Michael Landay; Yull E Arriaga
Journal:  J Investig Med High Impact Case Rep       Date:  2014-11-23

6.  Clinicopathological and histological analysis of secondary malignant giant cell tumors of bone without radiotherapy.

Authors:  Eiji Nakata; Hotaka Kawai; Tomohiro Fujiwara; Toshiyuki Kunisada; Hirofumi Inoue; Mashu Futagawa; Haruyoshi Katayama; Takuto Itano; Toshifumi Ozaki
Journal:  Oncol Lett       Date:  2022-07-19       Impact factor: 3.111

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.